CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Ordinary Shares	Ordinary Shares Performance-Based Restricted Stock Units (PRSUs)	Non-voting Euro Deferred	Capital Redemption Reserve	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2021			61,633		4,000
Beginning balance at Dec. 31, 2021	$ 3,965,191	$ (206,050)	$ 6		$ 55	$ 472	$ 3,534,792	$ (333,524)	$ (400,360)	$ 830,226	$ 127,474
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Issuance of ordinary shares in conjunction with exercise of share options (in shares)			832
Issuance of ordinary shares in conjunction with exercise of share options	82,897						82,897
Issuance of ordinary shares under employee stock purchase plan (in shares)			139
Issuance of ordinary shares under employee stock purchase plan	15,123						15,123
Issuance of ordinary shares in conjunction with vesting of restricted stock units and performance-based restricted stock units (in shares)			610
Shares withheld for payment of employee's withholding tax liability	(45,443)						(45,443)
Share-based compensation	223,279						223,279
Shares repurchased	(54)									(54)
Other comprehensive (loss) income	(725,149)								(725,149)
Net (loss) income	(224,060)									(224,060)
Ending balance (in shares) at Dec. 31, 2022			63,214		4,000
Ending balance at Dec. 31, 2022	3,085,734		$ 6		$ 55	472	3,477,124		(1,125,509)	733,586
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Issuance of ordinary shares in conjunction with exercise of share options (in shares)			280
Issuance of ordinary shares in conjunction with exercise of share options	30,189						30,189
Issuance of ordinary shares under employee stock purchase plan (in shares)			156
Issuance of ordinary shares under employee stock purchase plan	16,270						16,270
Issuance of ordinary shares in conjunction with vesting of restricted stock units and performance-based restricted stock units (in shares)			735
Shares withheld for payment of employee's withholding tax liability	(50,952)						(50,952)
Share-based compensation	227,323						227,323
Shares repurchased (in shares)			(2,130)
Shares repurchased	(269,761)					1				(269,762)
Other comprehensive (loss) income	283,362								283,362
Net (loss) income	$ 414,832									414,832
Ending balance (in shares) at Dec. 31, 2023	62,255		62,255		4,000
Ending balance at Dec. 31, 2023	$ 3,736,997		$ 6		$ 55	473	3,699,954		(842,147)	878,656
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Issuance of ordinary shares in conjunction with exercise of share options (in shares)	14		22
Issuance of ordinary shares in conjunction with exercise of share options	$ 1,629						1,629
Issuance of ordinary shares under employee stock purchase plan (in shares)			212
Issuance of ordinary shares under employee stock purchase plan	19,018						19,018
Issuance of ordinary shares in conjunction with vesting of restricted stock units and performance-based restricted stock units (in shares)			892	80
Shares withheld for payment of employee's withholding tax liability	(57,753)						(57,753)
Share-based compensation	250,694						250,694
Shares repurchased (in shares)			(2,830)
Shares repurchased	(311,429)									(311,429)
Other comprehensive (loss) income	(105,520)								(105,520)
Net (loss) income	$ 560,120									560,120
Ending balance (in shares) at Dec. 31, 2024	60,631		60,631		4,000
Ending balance at Dec. 31, 2024	$ 4,093,756		$ 6		$ 55	$ 473	$ 3,913,542		$ (947,667)	$ 1,127,347